cid,cmpdname,cmpdsynonym,mw,mf,polararea,complexity,xlogp,heavycnt,hbonddonor,hbondacc,rotbonds,inchi,isosmiles,canonicalsmiles,inchikey,iupacname,exactmass,monoisotopicmass,charge,covalentunitcnt,isotopeatomcnt,totalatomstereocnt,definedatomstereocnt,undefinedatomstereocnt,totalbondstereocnt,definedbondstereocnt,undefinedbondstereocnt,pclidcnt,gpidcnt,gpfamilycnt,neighbortype,meshheadings,annothits,annothitcnt,aids,cidcdate,sidsrcname,depcatg,annotation
137278711,Sotorasib,"Sotorasib|AMG-510|AMG510|2296729-00-3|Lumakras|2252403-56-6|AMG-510 racemate|AMG 510|Kras G12C inhibitor 9|sotorasibum|4-((S)-4-Acryloyl-2-methylpiperazin-1-yl)-6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidin-2(1H)-one|Kras mutant-targeting AMG 510|2B2VM6UC8G|Sotorasib [INN]|Sotorasib [USAN]|UNII-2B2VM6UC8G|CHEMBL4535757|CHEBI:178199|2296729-00-3 (racemate)|6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-propan-2-ylpyridin-3-yl)-4-[(2S)-2-methyl-4-prop-2-enoylpiperazin-1-yl]pyrido[2,3-d]pyrimidin-2-one|(1m)-6-Fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-(propan-2-yl)pyridin-3-yl)-4-((2S)-2-methyl-4-(prop-2-enoyl)piperazin-1-yl)pyrido(2,3-d)pyrimidin-2(1H)-one|2296729-66-1|6-Fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-propan-2-ylpyridin-3-yl)-4-((2S)-2-methyl-4-prop-2-enoylpiperazin-1-yl)pyrido(2,3-d)pyrimidin-2-one|Pyrido(2,3-d)pyrimidin-2(1H)-one, 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-(1-methylethyl)-3-pyridinyl)-4-((2S)-2-methyl-4-(1-oxo-2-propen-1-yl)-1-piperazinyl)-|(1RA)-6-FLUORO-7-(2-FLUORO-6-HYDROXYPHENYL)-4-((2S)-2-METHYL-4-(1-OXOPROP-2-EN-1-YL)PIPERAZIN-1-YL)-1-(4-METHYL-2-(PROPAN-2-YL)PYRIDIN-3-YL)PYRIDO(2,3-D)PYRIMIDIN-2(1H)-ONE|(1S)-4-((S)-4-Acryloyl-2-methylpiperazin-1-yl)-6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidin-2(1H)-one|6-FLUORO-7-(2-FLUORO-6-HYDROXYPHENYL)-(1M)-1-(4-METHYL-2-(PROPAN-2-YL)PYRIDIN-3-YL)-4-((2S)-2-METHYL-4-(PROP-2-ENOYL)PIPERAZIN-1-YL)PYRIDO(2,3-D)PYRIMIDIN-2(1H)-ONE|PYRIDO(2,3-D)PYRIMIDIN-2(1H)-ONE, 6-FLUORO-7-(2-FLUORO-6-HYDROXYPHENYL)-1-(4-METHYL-2-(1-METHYLETHYL)-3-PYRIDINYL)-4-((2S)-2-METHYL-4-(1-OXO-2-PROPEN-1-YL)-1-PIPERAZINYL)-, (1R)-|AMG510 racemate|compound (R)-38 (PMID: 31820981)|compound (R)-38 [PMID: 31820981]|Lumykras|6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-(propan-2-yl)pyridin-3-yl)-4-((2S)-2-methyl-4-(prop-2-enoyl)piperazin-1-yl)pyrido(2,3-d)pyrimidin-2(1H)-one|6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-[4-methyl-2-(propan-2-yl)pyridin-3-yl]-4-[(2S)-2-methyl-4-(prop-2-enoyl)piperazin-1-yl]pyrido[2,3-d]pyrimidin-2(1H)-one|Pyrido[2,3-d]pyrimidin-2(1H)-one, 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]-4-[(2S)-2-methyl-4-(1-oxo-2-propen-1-yl)-1-piperazinyl]-, (1R)-|AMG 510 racemate|AMG-510(racemate)|SOTORASIB [JAN]|Sotorasib [USAN:INN]|SOTORASIB RACEMATE|SOTORASIB [WHO-DD]|SOTORASIB [ORANGE BOOK]|SCHEMBL20560375|GTPL10678|C30H30F2N6O3|AMG 510 pound>>AMG-510|DTXSID001099260|GLXC-25372|AMY16918|BCP30452|BCP33368|EX-A3538|BDBM50514402|NSC818433|s8830|WHO 11370|AKOS037649138|DB15569|NSC-818433|AC-35168|BA172505|BA172506|BS-16684|HY-114277|CS-0081316|D70074|D77975|A930071|A934531|AMG510 ; AMG 510; AMG-510; AMG510|(1R)-4-((S)-4-Acryloyl-2-methylpiperazin-1-yl)-6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidin-2(1H)-one|6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(2-isopropyl-4-methylpyridin-3-yl)-4-[(2S)-2-methyl-4-(prop-2-enoyl)piperazin-1-yl]pyrido[2,3-d]pyrimidin-2-one|6-Fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-[4-methyl-2-(2-propanyl)-3-pyridinyl]-4-[(2S)-2-methyl-4-(2-propenoyl)-1-piperazinyl]pyrido[2,3-d]pyrimidin-2(1H)-one|6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-[4-methyl-2-(propan-2-yl)pyridin-3-yl]-4-[(2S)-2-methyl-4-(prop-2-enoyl)piperazin-1-yl]-1H,2H-pyrido[2,3-d]pyrimidin-2-one",560.600,C30H30F2N6O3,102.000,1030.000,4.000,41,1,7,5,"InChI=1S/C30H30F2N6O3/c1-6-23(40)36-12-13-37(18(5)15-36)28-19-14-21(32)26(24-20(31)8-7-9-22(24)39)34-29(19)38(30(41)35-28)27-17(4)10-11-33-25(27)16(2)3/h6-11,14,16,18,39H,1,12-13,15H2,2-5H3/t18-/m0/s1",C[C@H]1CN(CCN1C2=NC(=O)N(C3=NC(=C(C=C32)F)C4=C(C=CC=C4F)O)C5=C(C=CN=C5C(C)C)C)C(=O)C=C,CC1CN(CCN1C2=NC(=O)N(C3=NC(=C(C=C32)F)C4=C(C=CC=C4F)O)C5=C(C=CN=C5C(C)C)C)C(=O)C=C,NXQKSXLFSAEQCZ-SFHVURJKSA-N,"6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-propan-2-ylpyridin-3-yl)-4-[(2S)-2-methyl-4-prop-2-enoylpiperazin-1-yl]pyrido[2,3-d]pyrimidin-2-one",560.235,560.235,0,1,0,1,1,0,0,0,0,101,72,26,2D+3D,NULL,Biological Test Results|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing,11,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|1559567|1559568|1559569|1559570|1559571|1559572|1559573|1559574|1559575|1559576|1559577|1559578|1559579|1559582|1559583|1559584|1559585|1559586|1559587|1559588|1559589|1559590|1559591|1559592|1559593|1559594|1559595|1559596|1559597|1559599|1559600|1559601|1559602|1559603|1559604|1559605|1559606|1652156|1697072|1697073|1729513|1729514|1729515|1729516|1729517|1729518|1729519|1729520|1729521|1729522|1729523|1729524|1729525|1729526|1769392|1769393|1769394|1769395|1769396|1769397|1769398|1769399|1769400|1769401|1777598|1777599|1777600|1806575|1889606|1889607|1889608|1901007|1901008|1901009|1901010|1918456|1918457|1918458|1918459|1918460|1918470,20190126,"001Chemical|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|AbovChem LLC|AEchem Scientific Corp., USA|AKos Consulting & Solutions|Amadis Chemical|Ambeed|Apexmol|AstaTech, Inc.|Axon Medchem|BenchChem|BindingDB|BioChemPartner|Biosynth|BLD Pharm|BOC Sciences|ChEBI|Chem-Space.com Database|ChEMBL|Chemenu Inc.|ChemIDplus|ChemShuttle|Combi-Blocks|Comparative Toxicogenomics Database (CTD)|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DrugBank|DTP/NCI|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Glixx Labs Inc|Google Patents|Hangzhou APIChem Technology|Human Metabolome Database (HMDB)|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Key Organics/BIONET|Lan Pharmatech|MedChemexpress MCE|Molecule Market|MolPort|Nature Chemical Biology|PATENTSCOPE (WIPO)|Probes & Drugs portal|PubChem Reference Collection|Selleck Chemicals|Smolecule|Starshine Chemical|SureChEMBL|TargetMol|THE BioTek|Thieme Chemistry|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Research and Development|Subscription Services,"C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1902 - Ras Inhibitor|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor|D000970 - Antineoplastic Agents > D000074322 - Antineoplastic Agents, Immunological > D000082082 - Immune Checkpoint Inhibitors|L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents"
121328278,Linrodostat,"Linrodostat|BMS-986205|1923833-60-6|BMS986205|ONO-7701|BMS 986205|BMS-986205(Linrodostat)|CHEMBL4161733|CHEMBL4861395|ONO 7701|F-001287|(R)-N-(4-chlorophenyl)-2-((1s,4S)-4-(6-fluoroquinolin-4-yl)cyclohexyl)propanamide|0A7729F42K|1923833-60-6 (free base)|(2R)-N-(4-chlorophenyl)-2-[4-(6-fluoroquinolin-4-yl)cyclohexyl]propanamide|Linrodostat (USAN)|Linrodostat [USAN]|F 001287|(2R)-N-(4-chlorophenyl)-2-[4-(6-fluoroquinolin-4-yl)cyclohexyl]propanamid|LINRODOSTAT [INN]|C24H24ClFN2O|LINRODOSTAT [WHO-DD]|Linrodostat(BMS-986205)|GTPL9707|CHEMBL4297598|SCHEMBL17740982|SCHEMBL18826792|SCHEMBL19105151|SCHEMBL21374258|UNII-0A7729F42K|ONO7701|EX-A2606|BDBM50285416|BDBM50567127|BDBM50590772|NSC799771|s8629|AKOS032954040|CCG-268781|DB14986|NSC-799771|Compound 2 [PMID: 29531094]|AC-35890|AS-56267|BB165429|Example 19 [US20160137652A1]|HY-101560|CS-0021719|C73666|D11412|A902559|F001287|Q29213697|(2R)-N-(4-Chlorophenyl)-2-(4-(6-fluoro-4-quinolyl)cyclohexyl)propanamide, cis|(2R)-N-(4-CHLOROPHENYL)-2-(4-(6-FLUORO-4-QUINOLYL)CYCLOHEXYL)PROPANAMIDE, CIS-|(2R)-N-(4-Chlorophenyl)-2-(cis-4-(6-fluoro-4-quinolinyl)cyclohexyl)propanamide|(R)-N-(4-Chlorophenyl)-2-((1r,4R)-4-(6-fluoroquinolin-4-yl)cyclohexyl)propanamide|(R)-N-(4-Chlorophenyl)-2-(cis-4-(6-fluoroquinolin-4-yl)cyclohexyl)propanamide|Cyclohexaneacetamide, N-(4-chlorophenyl)-4-(6-fluoro-4-quinolinyl)-AA+/--methyl-, cis-|(R)-N-(4-chlorophenyl)-2-((1s,4S)-4-(6-fluoroquinolin-4-yl)cyclohexyl)propanamide;(R)-N-(4-chlorophenyl)-2-((1s,4S)-4-(6-fluoroquinolin-4-yl)cyclohexyl)propanamide|CYCLOHEXANEACETAMIDE, N-(4-CHLOROPHENYL)-4-(6-FLUORO-4-QUINOLINYL)-.ALPHA.-METHYL-, CIS-(.ALPHA.R)-|Cyclohexaneacetamide, N-(4-chlorophenyl)-4-(6-fluoro-4-quinolinyl)-alpha-methyl-, cis-(alphaR)-",410.900,C24H24ClFN2O,42.000,545.000,6.500,29,1,3,4,"InChI=1S/C24H24ClFN2O/c1-15(24(29)28-20-9-6-18(25)7-10-20)16-2-4-17(5-3-16)21-12-13-27-23-11-8-19(26)14-22(21)23/h6-17H,2-5H2,1H3,(H,28,29)/t15-,16?,17?/m1/s1",C[C@H](C1CCC(CC1)C2=C3C=C(C=CC3=NC=C2)F)C(=O)NC4=CC=C(C=C4)Cl,CC(C1CCC(CC1)C2=C3C=C(C=CC3=NC=C2)F)C(=O)NC4=CC=C(C=C4)Cl,KRTIYQIPSAGSBP-KLAILNCOSA-N,(2R)-N-(4-chlorophenyl)-2-[4-(6-fluoroquinolin-4-yl)cyclohexyl]propanamide,410.156,410.156,0,1,0,1,1,0,0,0,0,29,63,23,2D+3D,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry,8,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|1347060|1347064|1347065|1347067|1347068|1347411|1348816|1348819|1508605|1508606|1548538|1557406|1557407|1557408|1558484|1558485|1645845|1645846|1645870|1645876|1645877|1659683|1661736|1684410|1684412|1684413|1684419|1684420|1684424|1684435|1684437|1684708|1684709|1684710|1684711|1684712|1684713|1684714|1684715|1684716|1684717|1684718|1684719|1684721|1684722|1684723|1684724|1685291|1685296|1685346|1685347|1685350|1685351|1685352|1719795|1719796|1719797|1719798|1719799|1719822|1719824|1719826|1728718|1752240|1765813|1765814|1765816|1765819|1834381|1855349|1882076|1897023|1897039|1897040|1897058|1897067|1897069|1897072|1897075|1897076|1916192|1916193|1916774,20160806,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|AbMole Bioscience|Achemtek|Acorn PharmaTech Product List|AKos Consulting & Solutions|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|AstaTech, Inc.|BenchChem|BindingDB|Biosynth|BOC Sciences|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|ChEMBL|Chemenu Inc.|ChemIDplus|ChemShuttle|Combi-Blocks|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DrugBank|DTP/NCI|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|eNovation Chemicals|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Google Patents|Hangzhou APIChem Technology|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|KEGG|Key Organics/BIONET|Lan Pharmatech|LGC Standards|MedChemexpress MCE|Molecule Market|MolPort|MuseChem|Nature Portfolio Journals|NCBI Structure|NIH/NCATS RNAi|PATENTSCOPE (WIPO)|Probes & Drugs portal|Protein Data Bank in Europe (PDBe)|Selleck Chemicals|Smolecule|Springer Nature|Starshine Chemical|SureChEMBL|TargetMol|THE BioTek|Thieme Chemistry|Up-Fluorochem|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C274 - Antineoplastic Agent|C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent|C308 - Immunotherapeutic Agent > C141144 - Immune Checkpoint Modulator|C471 - Enzyme Inhibitor > C141137 - IDO1 Inhibitor|D004791 - Enzyme Inhibitors
45259014,Lisavanbulin,"Lisavanbulin|BAL101553|Lisavanbulin [INN]|Lisavanbulin [USAN]|BAL-101553|5PT0QP06X5|1263384-43-5|Lisavanbulin [USAN:INN]|UNII-5PT0QP06X5|WHO 10401|MICROTUBULE-TARGETED AGENT BAL101553|Hexanamide, 2,6-diamino-N-(4-(2-(2-(4-((2-cyanoethyl)amino)-1,2,5-oxadiazol-3-yl)-1H-benzimidazol-1-yl)acetyl)phenyl)-, (2S)-|(2S)-2,6-Diamino-N-(4-(2-(2-(4-((2-cyanoethyl)amino)-1,2,5-oxadiazol-3-yl)-1H-benzimidazol-1-yl)acetyl)phenyl)hexanamide|(2S)-2,6-Diamino-N-{4-[2-(2-{4-[(2-cyanoethyl)amino]-1,2,5-oxadiazol-3-yl}-1H-benzimidazol-1-yl)acetyl]phenyl}hexanamide|Lisavanbulin (USAN/INN)|LISAVANBULIN [WHO-DD]|SCHEMBL1160313|CHEMBL4297595|GLXC-25728|EX-A4306|NSC764608|NSC789724|BAL 101553|DB15224|NSC-764608|NSC-789724|D11494|Q27262705",515.600,C26H29N9O3,191.000,828.000,1.500,38,4,10,13,"InChI=1S/C26H29N9O3/c27-13-4-3-6-19(29)26(37)31-18-11-9-17(10-12-18)22(36)16-35-21-8-2-1-7-20(21)32-25(35)23-24(34-38-33-23)30-15-5-14-28/h1-2,7-12,19H,3-6,13,15-16,27,29H2,(H,30,34)(H,31,37)/t19-/m0/s1",C1=CC=C2C(=C1)N=C(N2CC(=O)C3=CC=C(C=C3)NC(=O)[C@H](CCCCN)N)C4=NON=C4NCCC#N,C1=CC=C2C(=C1)N=C(N2CC(=O)C3=CC=C(C=C3)NC(=O)C(CCCCN)N)C4=NON=C4NCCC#N,NIPZLALJRAHABJ-IBGZPJMESA-N,"(2S)-2,6-diamino-N-[4-[2-[2-[4-(2-cyanoethylamino)-1,2,5-oxadiazol-3-yl]benzimidazol-1-yl]acetyl]phenyl]hexanamide",515.239,515.239,0,1,0,1,1,0,0,0,0,11,181,39,2D+3D,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry,8,1|3|5|7|9|13|15|19|23|25|29|31|33|37|41|43|45|47|53|55|59|65|67|71|73|77|79|81|83|85|89|91|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145,20100503,"001Chemical|ChEMBL|ChemIDplus|DiscoveryGate|DrugBank|DTP/NCI|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Glixx Labs Inc|Google Patents|IBM|KEGG|Lan Pharmatech|MolPort|PATENTSCOPE (WIPO)|Probes & Drugs portal|Springer Nature|Starshine Chemical|SureChEMBL|Thomson Pharma",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent|D000970 - Antineoplastic Agents > D000074322 - Antineoplastic Agents, Immunological > D000082082 - Immune Checkpoint Inhibitors"
130205852,Quemliclustat,"AB-680|Quemliclustat|2105904-82-1|AB680|Quemliclustat [USAN]|J6K8WSV73A|UNII-J6K8WSV73A|CHEMBL4471306|WHO 11621|[[(2~{R},3~{S},4~{R},5~{R})-5-[6-chloranyl-4-[[(1~{S})-1-(2-fluorophenyl)ethyl]amino]pyrazolo[3,4-b]pyridin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]methylphosphonic acid|[[(2R,3S,4R,5R)-5-[6-chloro-4-[[(1S)-1-(2-fluorophenyl)ethyl]amino]pyrazolo[3,4-b]pyridin-1-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid|Quemliclustat [WHO-DD]|QUEMLICLUSTAT [INN]|CD73 inhibitor AB-680|SCHEMBL19100484|GTPL10707|EX-A4998|BDBM50527134|AKOS040732358|AC-36768|BA178946|HY-125286|CS-0090231|F78354|(((((2R,3S,4R,5R)-5-(6-chloro-4-(((S)-1-(2-fluorophenyl)ethyl)amino)-1H-pyrazolo[3,4-b]pyridin-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)methyl)phosphonic acid|(((2r,3s,4r,5r)-5-(6-chloro-4-((s)-1-(2-fluorophenyl)ethylamino)-1h-pyrazolo[3,4-b]pyridin-1-yl)-3,4-dihydroxytetrahydrofuran-2-ylmethoxy)(hydroxy)phosphorylmethyl)phosphonic acid|1H-Pyrazolo[3,4-b]pyridin-4-amine, 6-chloro-N-[(1S)-1-(2-fluorophenyl)ethyl]-1-[5-O-[hydroxy(phosphonomethyl)phosphinyl]-beta-D-ribofuranosyl]-|2-chloro-N6 -[(1S)-1-(2-fluorophenyl)ethyl]-8-aza-1,7- dicarbaadenosine 5'- (trihydrogen 2-carbadiphosphate)|QDH",580.800,C20H24ClFN4O9P2,197.000,893.000,-0.700,37,6,13,9,"InChI=1S/C20H24ClFN4O9P2/c1-10(11-4-2-3-5-13(11)22)24-14-6-16(21)25-19-12(14)7-23-26(19)20-18(28)17(27)15(35-20)8-34-37(32,33)9-36(29,30)31/h2-7,10,15,17-18,20,27-28H,8-9H2,1H3,(H,24,25)(H,32,33)(H2,29,30,31)/t10-,15+,17+,18+,20+/m0/s1",C[C@@H](C1=CC=CC=C1F)NC2=CC(=NC3=C2C=NN3[C@H]4[C@@H]([C@@H]([C@H](O4)COP(=O)(CP(=O)(O)O)O)O)O)Cl,CC(C1=CC=CC=C1F)NC2=CC(=NC3=C2C=NN3C4C(C(C(O4)COP(=O)(CP(=O)(O)O)O)O)O)Cl,MFYLCAMJNGIULC-KCVUFLITSA-N,"[[(2R,3S,4R,5R)-5-[6-chloro-4-[[(1S)-1-(2-fluorophenyl)ethyl]amino]pyrazolo[3,4-b]pyridin-1-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid",580.069,580.069,0,1,0,5,5,0,0,0,0,9,17,6,2D,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry,8,1605331|1606469|1674267|1674268|1674269|1674270|1674271|1674272|1674273|1674274|1674275|1674276|1674277|1674278|1674279|1674280|1674281|1674282|1674283|1674284|1674285|1674286|1674287|1674288|1674289|1674290|1674291|1674292|1674293|1674294|1674295|1674296|1674297|1674298|1674299|1674300|1674301|1674302|1674303|1674304|1674305|1674306|1674307|1674308|1674309|1674310|1674311|1674312|1674313|1674314|1674315|1674316|1674317|1674318|1674321|1692591|1724307|1724308|1724312|1919762,20171007,"AbaChemScene|AbMole Bioscience|AKos Consulting & Solutions|AstaTech, Inc.|Axon Medchem|BenchChem|BindingDB|Biosynth|Chem-Space.com Database|ChEMBL|ChemIDplus|ChemShuttle|Combi-Blocks|CymitQuimica|DC Chemicals|DTP/NCI|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Google Patents|Hangzhou APIChem Technology|IUPHAR/BPS Guide to PHARMACOLOGY|Lan Pharmatech|MedChemexpress MCE|MolPort|Nature Portfolio Journals|NCBI Structure|PATENTSCOPE (WIPO)|Probes & Drugs portal|Protein Data Bank in Europe (PDBe)|Starshine Chemical|Sun-shine Chemical|SureChEMBL|TargetMol",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Research and Development,"C274 - Antineoplastic Agent|C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent|D000970 - Antineoplastic Agents > D000074322 - Antineoplastic Agents, Immunological > D000082082 - Immune Checkpoint Inhibitors"
130358571,U2UY9Tbq8Z,"phi-101|phi101|U2UY9TBQ8Z|UNII-U2UY9TBQ8Z|2127107-15-5|N-(2-(N-((3S)(3-Piperidyl))carbamoyl)-5-(2-(3-fluorophenyl)ethynyl)(3-thienyl))aminamide|2-Thiophenecarboxamide, 3-((aminocarbonyl)amino)-5-(2-(3-fluorophenyl)ethynyl)-N-(3S)-3-piperidinyl-|2-Thiophenecarboxamide, 3-[(aminocarbonyl)amino]-5-[2-(3-fluorophenyl)ethynyl]-N-(3S)-3-piperidinyl-|CHEMBL4802136|SCHEMBL19274882|EX-A7852|HY-153857|CS-0865445",386.400,C19H19FN4O2S,125.000,619.000,2.600,27,4,5,5,"InChI=1S/C19H19FN4O2S/c20-13-4-1-3-12(9-13)6-7-15-10-16(24-19(21)26)17(27-15)18(25)23-14-5-2-8-22-11-14/h1,3-4,9-10,14,22H,2,5,8,11H2,(H,23,25)(H3,21,24,26)/t14-/m0/s1",C1C[C@@H](CNC1)NC(=O)C2=C(C=C(S2)C#CC3=CC(=CC=C3)F)NC(=O)N,C1CC(CNC1)NC(=O)C2=C(C=C(S2)C#CC3=CC(=CC=C3)F)NC(=O)N,ULVAGWVTXBTFRN-AWEZNQCLSA-N,3-(carbamoylamino)-5-[2-(3-fluorophenyl)ethynyl]-N-[(3S)-piperidin-3-yl]thiophene-2-carboxamide,386.121,386.121,0,1,0,1,1,0,0,0,0,1,26,4,2D+3D,NULL,Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry,5,NULL,20171007,AbaChemScene|ChEMBL|ChemIDplus|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Google Patents|MedChemexpress MCE|PATENTSCOPE (WIPO)|Probes & Drugs portal|Starshine Chemical|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,"C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor|D000970 - Antineoplastic Agents > D000074322 - Antineoplastic Agents, Immunological > D000082082 - Immune Checkpoint Inhibitors"
